Obtibrium StarDrop new capabilities

New bioisosteric transformations and predictive toxicity capabilities in 


Optibrium’s StarDrop software platform guides decisions in drug discovery to quickly identify chemistries with a high chance of success. StarDrop’s unique probabilistic scoring approach to multi-parameter optimization intuitively integrates predicted and experimental data to guide the design and selection of compounds that balance the many requirements for a high quality lead or candidate drug.

The release of StarDrop version 5.4 will introduce new modules to the suite of plug-ins that extend StarDrop’s core capabilities. The addition of the new Derek Nexus module, developed in collaboration with Lhasa Limited, will provide access to the world-leading technology for knowledge-based prediction of key toxicities in over 40 endpoints including mutagenicity, hepatotoxicity, and cardiotoxicity.

The capabilities of StarDrop’s existing Nova module will also be expanded by the addition of the BIOSTER database from Digital Chemistry to simulate the search for high-quality compounds by generating relevant compound ideas prioritized against a project’s property requirements. The BIOSTER module contains a unique compilation of over 20,000 precedented bioisosteric transformations, manually curated from the literature. The combination of Nova and BIOSTER will enable the application of this comprehensive database to generate novel structures with a high likelihood of biological activity and synthetic accessibility.

The combination of these technologies with StarDrop will enable chemists to intuitively design high-quality compounds, balancing the reduction of toxicity risk with all the other requirements for a successful, safe, and efficacious drug in hit-to-lead and lead optimization.

If you would like to know more, please download a brochure from http://www.optibrium.com/stardrop/brochure.php, visit www.optibrium.com or email info@optibrium.com to arrange a demonstration or free evaluation.